Comparison
6q16 Deletion Syndrome C5438727 vs Abca4 Related Disorder Cn239167
Clinical comparison between 6q16 Deletion Syndrome and Abca4 Related Disorder CN239167 for differential diagnosis and treatment planning.
6q16 Deletion Syndrome C5438727
A rare disorder caused by deletion of genetic material from chromosome 6. This primarily affects brain development and may cause developmental delays, behavioral differences, and distinctive facial features. Care involves multidisciplinary support.
Abca4 Related Disorder Cn239167
A genetic retinal disorder caused by ABCA4 gene mutations affecting light-sensing cells in the eye, leading to progressive vision loss that typically begins in childhood or adolescence.
6 comparison axes
Onset
6q16 Deletion Syndrome C5438727
Variable
Abca4 Related Disorder Cn239167
5-30
Onset patterns differ
Severity
6q16 Deletion Syndrome C5438727
moderate
Abca4 Related Disorder Cn239167
moderate
Different severity levels
Chronic
6q16 Deletion Syndrome C5438727
Chronic
Abca4 Related Disorder Cn239167
Chronic
Differing course
Communicable
6q16 Deletion Syndrome C5438727
No
Abca4 Related Disorder Cn239167
No
Different transmission
Body System
6q16 Deletion Syndrome C5438727
congenital
Abca4 Related Disorder Cn239167
ophthalmologic
Same/different system
Category
6q16 Deletion Syndrome C5438727
genetic
Abca4 Related Disorder Cn239167
genetic
Different category
Bottom line
6q16-deletion-syndrome-C5438727 and abca4-related-disorder-CN239167 have similar characteristics
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 6q16 Deletion Syndrome C5438727 | Abca4 Related Disorder Cn239167 | Discriminating power |
|---|---|---|---|
| Developmental delay | May include developmental delay and behavioral differences from early life. | Not a defining feature; cognition is not the primary target. | High |
| Vision change | Vision loss is not the core described feature. | Progressive vision loss often begins in childhood or adolescence. | High |
| Facial features | Distinctive facial features may occur. | No characteristic facial phenotype is established here. | Moderate |
When to favor each condition
Choose 6q16 Deletion Syndrome C5438727 when
Neurodevelopmental concerns
Choose evaluation for 6q16 deletion when delay, behavior, and congenital features predominate.
High
Suspected chromosomal deletion
Chromosomal microarray or equivalent testing is more relevant than retinal gene testing.
Moderate
Multisystem congenital presentation
A congenital syndrome framework fits better than an isolated retinal disorder.
Moderate
Choose Abca4 Related Disorder Cn239167 when
Progressive childhood vision loss
ABCA4-related disease is favored when retinal symptoms are the main problem.
High
Retinal imaging abnormalities
Ophthalmic findings should prompt ABCA4-focused evaluation.
Moderate
Family history of retinal dystrophy
A retinal genetic pattern supports ABCA4 testing rather than 6q16 assessment.
Moderate
How key tests differ
| Test | 6q16 Deletion Syndrome C5438727 | Abca4 Related Disorder Cn239167 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | May identify a 6q16 deletion. | Not expected to diagnose ABCA4 disease. | A deletion finding supports the left condition but needs clinician confirmation. |
| ABCA4 genetic testing | Not the primary test for a chromosomal deletion. | May identify disease-related ABCA4 variants. | Variant interpretation requires specialist review; a result alone is not a full diagnosis. |
| Ophthalmic examination | No specific retinal pattern is established in the source. | May show retinal changes associated with progressive vision loss. | Abnormal eye findings suggest retinal disease but do not by themselves prove ABCA4 causation. |
Prognosis comparison
6q16 Deletion Syndrome C5438727
- Outcome
- A chronic congenital condition with variable developmental impact; exact outcomes are not established here.
- Factors
- Deletion extent, associated findings, and access to support may influence needs.
Abca4 Related Disorder Cn239167
- Outcome
- A chronic retinal disorder with possible progressive vision loss; individual course is variable.
- Factors
- Age at onset, genotype, and retinal findings may influence course, but cutoffs are not provided.
Time frame: Both are long-term; ABCA4 symptoms are described from about ages 5 to 30, while 6q16 onset is variable.
Prognosis should be individualized by a clinician; no mortality or prevalence figures are supplied.
Complications comparison
| Complication | Presentation |
|---|---|
| Learning and behavior needs | Developmental and behavioral support needs may be substantial. Not the primary complication described. Needs vary; exact frequency is not established here. |
| Progressive visual impairment | Not described as the central course. Vision may worsen over time, often from childhood or adolescence. Rate and severity are variable and should not be assumed. |
| Care coordination burden | Often needs developmental, genetic, and educational coordination. Often needs ophthalmology, low-vision, and genetic counseling support. Both are chronic, but the specialist mix differs. |
Patient education highlights
- HighDifferent organ focus
One condition centers on brain development; the other centers on retinal cells and vision.
- HighGenetic confirmation
A suspected label should be confirmed with appropriate genetic and clinical evaluation.
- MediumSupport planning
Ask clinicians about developmental services or low-vision support based on the confirmed diagnosis.